ABMS 5313

Medical Product Development & FDA Regulations.

Sam Houston State University · UGRD · Fall 2026

1 section
Add to a schedule

Catalog description

Students examine regulatory processes for the development and approval of medical products with an emphasis on U.S. Food and Drug Administration (FDA) requirements. Topics may include pre-clinical studies, Investigational New Drug (IND) applications, clinical trial phases, and New Drug Application (NDA) or Premarket Approval (PMA) submissions. Students analyze FDA oversight of labeling, post-market surveillance, and adverse event reporting. Students investigate regulatory pathways for medical devices, drugs, biologics, and combination products, and evaluate common challenges companies encounter in achieving compliance. Prerequisite: ABMS 5301 , ABMS 5302 , ABMS 5303 & ABMS 5304 .

Sections

Current meeting, instructor, credit, and enrollment details

Updated 3 hours ago

001

Availability not recently verified
Class #sam_houston-0184Fall 2026UGRD3 credits
Days & times
No scheduled meeting time
Meeting dates
Location
Instructor
Staff
Class numbers and section codes come from the registrar.
Spot missing or incorrect course data?